Abstract
The nasal route of immunization has become a real alternative to injections. It is indeed described as more efficient at inducing immune protection, since it initiates both mucosal and systemic immunity, thus protecting against both the infection itself and the transmission of pathogens by the host. However, the use of immunomodulators should be limited since they induce inflammation. Here we investigated in vitro the mechanisms underlying the enhancement of antigen immunogenicity by starch nanoparticles (NPL) delivery systems in H292 epithelial cells, as well as the NPL’s immunomodulatory effect. We observed that NPL had no intrinsic immunomodulatory effect but enhanced the immunogenicity of an E. coli lysate (Ag) merely by increasing its intracellular delivery. Moreover, we demonstrated the importance of the NPL density on their efficiency by comparing reticulated (NPL) and non-reticulated particles (NPL·NR). These results show that an efficient delivery system is sufficient to induce a mucosal immune response without the use of immunomodulators.
Publisher
Public Library of Science (PLoS)
Reference55 articles.
1. “A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge,” Nat;S. Wu;Commun.,2020
2. “Intranasal formulations: promising strategy to deliver vaccines,” Expert Opin;P. Riese;Drug Deliv.,2014
3. “NALT- versus PEYER’S-patch-mediated mucosal immunity,” Nat;H. Kiyono;Rev. Immunol.,2004
4. “Vaccines for the twenty-first century society,” Nat;R. Rappuoli;Rev. Immunol.,2011
5. “Are we entering a new age for human vaccine adjuvants?,”;D. T. O’Hagan;Expert Rev. Vaccines,2015
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献